InvestorsHub Logo

Rawnoc

01/31/15 6:58 PM

#107764 RE: FORZANANO #107763

Jan 30 (Reuters) - Drug developer Chimerix Inc said it would stop participation in clinical studies of its Ebola drug, brincidofovir, citing a significant decrease in the number new cases for the virus in Liberia.

http://www.reuters.com/article/2015/01/31/health-ebola-chimerix-idUSL4N0V98ER20150131

Rut roh!

Magnus1

01/31/15 7:46 PM

#107770 RE: FORZANANO #107763

NNVC designs, creates and delivers CIDES in facilities they own...I don't see the controversy...but I do hear the whining...lol.